Nanoparticles for cancer imaging: The good, the bad, and the promise

Abstract

Summary Recent advances in molecular imaging and nanotechnology are providing new opportunities for biomedical imaging with great promise for the development of novel imaging agents. The unique optical, magnetic, and chemical properties of materials at the scale of nanometers allow the creation of imaging probes with better contrast enhancement, increased sensitivity, controlled biodistribution, better spatial and temporal information, multi-functionality and multi-modal imaging across MRI, PET, SPECT, and ultrasound. These features could ultimately translate to clinical advantages such as earlier detection, real time assessment of disease progression and personalized medicine. However, several years of investigation into the application of these materials to cancer research has revealed challenges that have delayed the successful application of these agents to the field of biomedical imaging. Understanding these challenges is critical to take full advantage of the benefits offered by nano-sized imaging agents. Therefore, this article presents the lessons learned and challenges encountered by a group of leading researchers in this field, and suggests ways forward to develop nanoparticle probes for cancer imaging. Published by Elsevier Ltd.

Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier

“…These new nanomaterials may provide new opportunities for biomedical imaging, due to their unique magnetic, optical, and/or chemical properties, leading to the creation of better contrast-enhancement agents and increasing the sensitivity of techniques clinically available for diagnosis of brain tumors. 284 Modern imaging techniques, such as magnetic resonance imaging (MRI), optical imaging, ultrasound, and single-photon-emission computed tomography (SPECT), are rapidly emerging as noninvasive modalities for detection and follow-up posttreatment of gliomas. 285,286 MRI is the preferred approach for glioma imaging, since it provides high-spatial-resolution anatomic images of this tumor type.…”

Isoniazid@Fe2O3‐Nanocontainer mit antibakterieller Wirkung auf Tuberkulose‐Mykobakterien

“…[1][2][3][4][5] Nanomaterialien bieten generell bereits vielversprechende Strategien für Molekularbiologie und Medizin. So wurde deren Verwendung für neuartige Bildgebungstechniken [6] oder die Tumortherapie in den letzten Jahren bereits intensiv untersucht. [7] Für die TB-Behandlung wären effiziente Transportsysteme zur Infiltration von Antibiotika in infizierte Zellen erforderlich.…”

Optically Modulated Theranostic Nanoparticles

“…Multiple imaging and therapeutic modalities are attractive in small animal models, but the therapy timing and concrete applications in human context are in their infancy. Some of the challenges for translation of nanoparticle based imaging are described by Chapman et al 57 Continued progress in pre-clinical studies and accumulation of safety and toxicity data for theranostic nanoparticles will likely attract attention and investments from the larger biotechnology and pharmaceutical industries and propel these therapies to clinic.…”